Clinical Trials Directory

Trials / Conditions / Tocilizumab

Tocilizumab

12 registered clinical trials studyying Tocilizumab — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingImmunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
NCT06624436
Radboud University Medical CenterPhase 4
WithdrawnEfficacy and Safety of Tocilizumab for TAO
NCT06087731
Sun Yat-sen UniversityPhase 2
CompletedCritically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application
NCT06233357
University of Ulm—
CompletedTocilizumab in Covid-19 Penumonia in Buenos Aires City
NCT05057962
Sanatorio Finochietto—
UnknownSafety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19
NCT04924829
Hospital Italiano de Buenos Aires—
WithdrawnHigh-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
NCT05133635
Marmara UniversityPhase 4
RecruitingA Pilot Study in Severe Patients With Takayasu Arteritis.
NCT04300686
Shanghai Zhongshan HospitalPhase 4
CompletedEffect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study
NCT04893031
Karadeniz Technical University—
UnknownTocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19
NCT04306705
Tongji Hospital—
CompletedUltra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients
NCT05394909
Azienda USL Reggio Emilia - IRCCS—
UnknownTherapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
NCT03781310
Tel-Aviv Sourasky Medical CenterPhase 4
CompletedCharacterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid
NCT02569736
Association Aquitaine de Recherche Clinique en Rhumatologie—